<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01298102</url>
  </required_header>
  <id_info>
    <org_study_id>Etude 2009/INT044</org_study_id>
    <nct_id>NCT01298102</nct_id>
  </id_info>
  <brief_title>Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Disease Patients</brief_title>
  <official_title>Safety and Efficacy of Influenza A/H1N1/2009-adjuvanted Vaccine in Renal Transplant and Dialyzed Patients: a Prospective Cohort Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Erasme University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Erasme University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In 2009, the pandemic influenza A/H1N1 accounted for worldwide recommendations about
      vaccination. There is no data concerning the immunogenicity nor the security of the
      adjuvanted-A/H1N1 vaccine in renal disease patients. The aim of this study is to observe the
      effects of this vaccine on transplanted and hemodialyzed patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The serologic responses to the Pandemrix vaccine will assess the efficacy, with the
      determination of the seroconversion rate among the patients.

      The anti-HLA and anti-MICA antibodies will be determined to assess the safety among the renal
      transplanted patients.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">March 2010</completion_date>
  <primary_completion_date type="Actual">March 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>to determine the efficacy aand safety of influenza A/H1N1 adjuvanted-vaccination among renal transplant and haemodialyzed patients as compared to controls</measure>
    <time_frame>one month post-vaccination</time_frame>
    <description>measures of anti-A/H1N1 antibodies with a method of microneutralizing test (seroneutralization) to follow-up the secondary effects of the vaccine and follow-up of renal function in renal transplanted patients.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>to controls and to assess the safety of the vaccine among renal transplanted patients by studying HLA or MICA sensitization before and following vaccination</measure>
    <time_frame>follow-up 6 months</time_frame>
    <description>To measure the Anti-HLA and anti-MICA antibodies with luminex-test</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">185</enrollment>
  <condition>Decreased Immunologic Activity [PE]</condition>
  <condition>Influenza</condition>
  <condition>Rejection</condition>
  <arm_group>
    <arm_group_label>influenza vaccine</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pandemrix vaccine (Influenza A/H1N1 2009)to be injected to renal transplant patients, haemodialyzed patients, and controls</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>Influenza A/H1N1 2009-AS03 adjuvanted (Pandemrix)</intervention_name>
    <description>intramuscular injection of 1 dose vaccine</description>
    <arm_group_label>influenza vaccine</arm_group_label>
    <other_name>Pandemrix</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult patients

          2. Haemodialyzed patients

          3. Renal transplant recipients who have stable renal function for the last 3 months

        Exclusion Criteria:

          1. No pneumonia or severe infection during 1 month before vaccination

          2. No Ivig (intravenous immunoglobulins) treatment during the last 3 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Daniel Abramowicz, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Hospital Erasme</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Erasme</name>
      <address>
        <city>Brussels</city>
        <state>Brabant</state>
        <zip>1070</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <reference>
    <citation>Candon S, Thervet E, Lebon P, Suberbielle C, Zuber J, Lima C, Charron D, Legendre C, Chatenoud L. Humoral and cellular immune responses after influenza vaccination in kidney transplant recipients. Am J Transplant. 2009 Oct;9(10):2346-54. doi: 10.1111/j.1600-6143.2009.02787.x. Epub 2009 Jul 28.</citation>
    <PMID>19656126</PMID>
  </reference>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 16, 2011</study_first_submitted>
  <study_first_submitted_qc>February 16, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 17, 2011</study_first_posted>
  <last_update_submitted>February 16, 2011</last_update_submitted>
  <last_update_submitted_qc>February 16, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 17, 2011</last_update_posted>
  <responsible_party>
    <name_title>Broeders Nilufer</name_title>
    <organization>Hospital Erasme</organization>
  </responsible_party>
  <keyword>kidney</keyword>
  <keyword>transplantation</keyword>
  <keyword>haemodialysis</keyword>
  <keyword>vaccination</keyword>
  <keyword>influenza H1N1 2009</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Influenza, Human</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vaccines</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

